Soil-borne plant pathogens characterize a critical risk that undermines industrial walnut (Juglans regia) manufacturing worldwide. Crown gall, attributable to Agrobacterium tumefaciens, and Phytophthora root and crown rots, attributable to varied Phytophthora spp., are among the many most devastating walnut soil-borne ailments.
A acknowledged technique to fight soil-borne ailments is adoption of resistant rootstocks. Right here, resistance to A. tumefaciens, P. cinnamomi, and P. pini is mapped within the genome of Juglans microcarpa, a North American wild relative of cultivated walnut. Half-sib J. microcarpa mom bushes DJUG 31.01 and DJUG 31.09 had been crossed with J. regia cv. Serr, producing 353 and 400 hybrids, respectively.
Clonally propagated hybrids had been genotyped by sequencing to assemble genetic maps for the 2 populations and challenged with the three pathogens. Resistance to every of the three pathogens was mapped as a serious QTL on the lengthy arm of J. microcarpa chromosome 4D and was related to the identical haplotype, designated as haplotype b, elevating the likelihood that the 2 mom bushes had been heterozygous for a single Mendelian gene conferring resistance to all three pathogens.
The deployment of this haplotype in rootstock breeding will facilitate breeding of a walnut rootstock immune to each crown gall and Phytophthora root and crown rots.
A number of Viral Infections Detected in Phytophthora condilina by Complete and Small RNA Sequencing
Marine oomycetes have lately been proven to be concurrently contaminated by (-)ssRNA viruses of the order Bunyavirales. On this work, even greater virus variability was present in a single isolate of Phytophthora condilina, a lately described member of Phytophthora phylogenetic Clade 6a, which was remoted from brackish estuarine waters in southern Portugal.
Utilizing complete and small RNA-seq the total RdRp of 13 totally different potential novel bunya-like viruses and two full toti-like viruses had been detected. All these viruses had been efficiently confirmed by reverse transcription polymerase chain response (RT-PCR) utilizing complete RNA as template, however complementarily one of many toti-like and 5 of the bunya-like viruses had been confirmed when dsRNA was purified for RT-PCR. In our examine, complete RNA-seq was by much more environment friendly for de novo assembling of the virus sequencing however small RNA-seq confirmed greater learn numbers for many viruses.
Two fundamental populations of small RNAs (21 nts and 25 nts-long) had been recognized, which had been in accordance with different Phytophthora species. To the very best of our information, that is the primary examine utilizing small RNA sequencing to determine viruses in Phytophthora spp.
Stepwise accumulation of mutations in CesA3 in Phytophthora sojae leads to rising resistance to CAA fungicides
Flumorph is a carboxylic acid amide (CAA) fungicide with excessive exercise towards oomycetes. Nonetheless, evolution to CAAs from low resistance to excessive resistance has by no means been reported. This examine investigated the premise of resistance evolution of flumorph in Phytophthora sojae.
Complete of 120 P. sojae isolates had been collected and their sensitivity to flumorph was evaluated. Though no spontaneous resistance was discovered among the many area isolates, adaptation on flumorph-amended media resulted within the collection of 5 steady mutant varieties exhibiting various levels of resistance to CAAs.
Kind I, which exhibited the bottom resistance stage, was obtained when the wild-type isolate was uncovered to a low focus of flumorph, however no resistant mutants had been obtained by direct publicity to greater concentrations. Nonetheless, the extra resistant varieties (Kind II, III, IV and V) had been obtained when Kind I had been uncovered to greater concentrations of flumorph.
Comparable outcomes had been obtained when your entire screening course of was repeated, which implied that evolution of resistance to flumorph in P. sojae could possibly be a two-step course of, the place excessive resistance phenotypes may develop regularly from low resistance ones.
Additional investigation into molecular mechanism strongly confirmed that evolution of isolates extremely immune to flumorph happens in a stepwise course of with Kind I as middleman, by means of accumulation of mutations of their goal protein of CAAs (CesA3). Collectively, our findings point out that software of low charges of flumorph in area may lead to collection of low resistance Kind I isolates, however that elevating dosage to keep up comparable ranges of management may elicit speedy evolution of extra resistant Kind II, III, IV and V isolates with stepwise accumulation of mutations in CesA3, which might render flumorph ineffective as a management technique.
NAD Kinase highly active Recombinant Protein |
|||
| 90-353 | ProSci | 50 ug | EUR 651.3 |
|
Description: NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis. |
|||
NF-kB p65 highly active Recombinant Protein |
|||
| 90-348 | ProSci | 2 ug | EUR 600.9 |
|
Description: NF-kappaB is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappaB is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric p65-p50 complex is the most abundant complex. The dimers bind at kappaB sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappaB sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappaB complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappaB inhibitor (I-kappaB) family. In a conventional activation pathway, I-kappaB is phosphorylated by I-kappaB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappaB complex which translocates to the nucleus. NF-kappaB heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappaB p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappaB complex. |
|||
NF-kB p50 highly active Recombinant Protein |
|||
| 90-349 | ProSci | 2 ug | EUR 632.4 |
|
Description: NF-kappaB is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappaB is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric p65-p50 complex is the most abundant complex. The dimers bind at kappaB sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappaB sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappaB complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappaB inhibitor (I-kappaB) family. In a conventional activation pathway, I-kappaB is phosphorylated by I-kappaB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappaB complex which translocates to the nucleus. NF-kappaB heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappaB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. |
|||
FGF acidic Recombinant Protein |
|||
| 40-493-001mg | ProSci | 0.01 mg | EUR 311.1 |
|
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant murine FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues. |
|||
FGF acidic Recombinant Protein |
|||
| 40-493-005mg | ProSci | 0.05 mg | EUR 437.1 |
|
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant murine FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues. |
|||
CREB-binding Protein highly active Recombinant Protein |
|||
| 90-344 | ProSci | 2 ug | EUR 500.1 |
|
Description: CREB-binding protein acetylates histones, giving a specific tag for transcriptional activation. It also acetylates non-histone proteins, like NCOA3 and FOXO1. It binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1 in the presence of EP300. |
|||
BAFF, Soluble 60-mer highly active Recombinant Protein |
|||
| 90-294 | ProSci | 10 ug | EUR 537.9 |
|
Description: BAFF is mainly produced by innate immune cells such as neutrophils, monocytes, macrophages, dendritic cells, follicular dendritic cells. T cells, activated B cells, some malignant B cells and also non-lymphoid cells like astrocytes, synoviocytes and epithelial cells can also produce BAFF. BAFF binds three distinct receptors (BAFF-R, TACI and BCMA) expressed predominantly on B cells, although activated T cells also express BAFF-R. BAFF is a master regulator of peripheral B cell survival, and together with IL-6, promotes Ig class-switching and plasma cell differentiation. Besides its major role in B cell biology, BAFF co-stimulates activated T cells. Deregulated expression of BAFF leads to autoimmune disorders in mice. In humans, elevated levels of soluble BAFF have been detected in the serum of patients with various autoimmune diseases such as Sjoegren syndrome, Rheumatoid arthritis (RA), Multiple sclerosis (MS) and Systemic Lupus Erythematosus (SLE). BAFF has also increased levels in some lymphoid cancers. Processed human BAFF can either remain as a trimer, which is usual for TNF family ligands or assemble into 60-mer composed of 20 trimers. Mouse BAFF 60-mer has been identified in the serum of BAFF transgenic mice. Oligomerization of BAFF 3-mer into 60-mer in human BAFF is prevented by mutation of His218, a residue critical for 3-mer-to-3-mer interactions, but not for receptor binding. Despite the predominant functional role of processed BAFF in vivo, membrane-bound BAFF might also play a role. Indeed, soluble BAFF (3-mer) can trigger BAFF-R but not TACI or BCMA, whereas oligomeric forms of BAFF (BAFF 60-mer), which mimic membrane-bound BAFF, activate all BAFF receptors. |
|||
NAD Kinase catalytic domain highly active Recombinant Protein |
|||
| 90-352 | ProSci | 50 ug | EUR 752.1 |
|
Description: NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis. |
|||
Genorise® recombinant monkey FGF Acidic |
|||
| GR175084 | Genorise Scientific | 5 mg | EUR 285 |
Recombinant human FGF acidic/FGF1 Protein |
|||
| RP01242 | Abclonal | 10 μg | EUR 178.8 |
Genorise® Recombinant Guinea Pig FGF Acidic |
|||
| GR177027 | Genorise Scientific | 5 mg | EUR 285 |
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Hu02 | Cloud-Clone |
|
|
|
Description: Recombinant Human Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Mu02 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Mu03 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Mu04 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Glial Fibrillary Acidic Protein (GFAP) |
|||
| 4-RPA068Ra02 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Glial Fibrillary Acidic Protein expressed in: E.coli |
|||
Recombinant Mouse FGF1/FGFa/FGF acidic Protein |
|||
| RP00487 | Abclonal | 10 μg | EUR 174 |
Recombinant FGF acidic Protein (Phe 16-Asp 155) |
|||
| VAng-1552Lsx-1mg | Creative Biolabs | 1 mg | EUR 2370 |
|
Description: Human FGF acidic is expressed in HEK 293 cells. (Uniprot ID: NP_000791) |
|||
Recombinant FGF acidic Protein (Phe 16-Asp 155) |
|||
| VAng-1552Lsx-200g | Creative Biolabs | 200 µg | EUR 654 |
|
Description: Human FGF acidic is expressed in HEK 293 cells. (Uniprot ID: NP_000791) |
|||
Genorise® recombinant human FGF acidic protein |
|||
| GR119085 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® recombinant Sheep FGF Acidic protein |
|||
| GR123010 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® recombinant Mouse FGF acidic protein |
|||
| GR124085 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine FGF Acidic protein |
|||
| GR104326 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® recombinant Bovine FGF Acidic protein |
|||
| GR120059 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® recombinant Canine FGF Acidic protein |
|||
| GR122083 | Genorise Scientific | 5 µg | EUR 285 |
Recombinant human Acidic repeat-containing protein |
|||
| P2170 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Acidic repeat-containing protein |
|||
Genorise® recombinant porcine FGF acidic protein |
|||
| GR189016 | Genorise Scientific | 5 µg | EUR 285 |
Recombinant Cryptochrome 1 (CRY1) |
|||
| 4-RPC407Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Cryptochrome 1 expressed in: E.coli |
|||
Recombinant Fibroblast Growth Factor 1, Acidic (FGF1) |
|||
| 4-RPA032Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Fibroblast Growth Factor 1, Acidic expressed in: E.coli |
|||
Recombinant Fibroblast Growth Factor 1, Acidic (FGF1) |
|||
| 4-RPA032Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Fibroblast Growth Factor 1, Acidic expressed in: E.coli |
|||
Recombinant Fibroblast Growth Factor 1, Acidic (FGF1) |
|||
| 4-RPA032Ov01 | Cloud-Clone |
|
|
|
Description: Recombinant Sheep Fibroblast Growth Factor 1, Acidic expressed in: E.coli |
|||
Recombinant Fibroblast Growth Factor 1, Acidic (FGF1) |
|||
| 4-RPA032Po01 | Cloud-Clone |
|
|
|
Description: Recombinant Pig Fibroblast Growth Factor 1, Acidic expressed in: E.coli |
|||
Recombinant Fibroblast Growth Factor 1, Acidic (FGF1) |
|||
| 4-RPA032Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Fibroblast Growth Factor 1, Acidic expressed in: E.coli |
|||
Proline-Rich Acidic Protein 1 Recombinant Protein |
|||
| 91-734 | ProSci | 0.05 mg | EUR 651.3 |
|
Description: Proline-rich acidic protein 1, also known as Uterine-specific proline-rich acidic protein, UPA and PRAP1, is a secreted protein. PRAP1 is abundantly expressed in the epithelial cells of the liver, kidney, gastrointestinal tract and cervix. PRAP1 is up-regulated by butyrate, trichostatin A and 5'-aza-2' deoxycytidine. PRAP1 may play an important role in maintaining normal growth homeostasis in epithelial cells. PRAP1 is suppressed through epigenetic mechanisms involving histone deacetylation and methylation. PRAP1 has been shown to cause cell growth inhibition in cancer cell lines. |
|||
Recombinant Human Secreted Protein Acidic & Rich in Cysteine |
|||
| 7-06505 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Secreted Protein Acidic & Rich in Cysteine |
|||
| 7-06506 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Secreted Protein Acidic & Rich in Cysteine |
|||
| 7-06507 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Cytokeratin, Acidic Protein, His, Yeast-1mg |
|||
| QP7778-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant Human Cytokeratin, Acidic Protein, His, Yeast-10ug |
|||
| QP7778-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human Cytokeratin, Acidic Protein, His, Yeast-50ug |
|||
| QP7778-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Human Cytokeratin, Acidic Protein, His, Yeast-100ug |
|||
| QP7778-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human Cytokeratin, Acidic Protein, His, Yeast-200ug |
|||
| QP7778-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human Cytokeratin, Acidic Protein, His, Yeast-500ug |
|||
| QP7778-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant human Phosphofurin acidic cluster sorting protein 1 |
|||
| P2221 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Phosphofurin acidic cluster sorting protein 1 |
|||
Recombinant human Phosphofurin acidic cluster sorting protein 2 |
|||
| P2696 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Phosphofurin acidic cluster sorting protein 2 |
|||
Recombinant Acidic Salivary Proline Rich Phosphoprotein 2 (PRH2) |
|||
| 4-RPD812Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Acidic Salivary Proline Rich Phosphoprotein 2 expressed in: E.coli |
|||
Recombinant Human Glial Fibrillary Acidic Protein/GFAP (N-6His) |
|||
| C227-10ug | Novoprotein | 10ug | EUR 242.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.25. |
|||
Recombinant Human Glial Fibrillary Acidic Protein/GFAP (N-6His) |
|||
| C227-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.25. |
|||
Recombinant Human Glial Fibrillary Acidic Protein/GFAP (N-6His) |
|||
| C227-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.25. |
|||
Recombinant Human Glial Fibrillary Acidic Protein/GFAP (N-6His) |
|||
| C227-50ug | Novoprotein | 50ug | EUR 595.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.25. |
|||
PRAP1 Proline-Rich Acidic Protein 1 Human Recombinant Protein |
|||
| PROTQ96NZ9 | BosterBio | Regular: 10ug | EUR 380.4 |
|
Description: PRAP1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (a.a 21-151) containing 141 amino acids including a 10 a.a N-terminal His tag. The total molecular mass is 16.2kDa (calculated). |
|||
Recombinant Human Proline-Rich Acidic Protein 1/PRAP1 (C-6His) |
|||
| CA24-10ug | Novoprotein | 10ug | EUR 187.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Proline-Rich Acidic Protein 1/PRAP1 (C-6His) |
|||
| CA24-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Proline-Rich Acidic Protein 1/PRAP1 (C-6His) |
|||
| CA24-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Proline-Rich Acidic Protein 1/PRAP1 (C-6His) |
|||
| CA24-50ug | Novoprotein | 50ug | EUR 442.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Acidic Nuclear Phosphoprotein 32 Family, Member A |
|||
| 7-04315 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Acidic Nuclear Phosphoprotein 32 Family, Member A |
|||
| 7-04316 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Acidic Nuclear Phosphoprotein 32 Family, Member A |
|||
| 7-04317 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Cytokeratin, Acidic Protein, His-SUMO, E.coli-10ug |
|||
| QP7778-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human Cytokeratin, Acidic Protein, His-SUMO, E.coli-1mg |
|||
| QP7778-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human Cytokeratin, Acidic Protein, His-SUMO, E.coli-50ug |
|||
| QP7778-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human Acidic mammalian chitinase Protein, GST, E.coli-1mg |
|||
| QP8133-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Acidic Nuclear Phosphoprotein 32 Family, Member A (ANP32A) |
|||
| 4-RPJ636Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Acidic Nuclear Phosphoprotein 32 Family, Member A expressed in: E.coli |
|||
Recombinant Acidic Nuclear Phosphoprotein 32 Family, Member A (ANP32A) |
|||
| 4-RPJ636Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Acidic Nuclear Phosphoprotein 32 Family, Member A expressed in: E.coli |
|||
Recombinant Human Cytokeratin, Acidic Protein, His-SUMO, E.coli-100ug |
|||
| QP7778-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human Cytokeratin, Acidic Protein, His-SUMO, E.coli-200ug |
|||
| QP7778-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human Cytokeratin, Acidic Protein, His-SUMO, E.coli-500ug |
|||
| QP7778-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human Acidic mammalian chitinase Protein, GST, E.coli-100ug |
|||
| QP8133-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human Acidic mammalian chitinase Protein, GST, E.coli-10ug |
|||
| QP8133-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human Acidic mammalian chitinase Protein, GST, E.coli-200ug |
|||
| QP8133-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human Acidic mammalian chitinase Protein, GST, E.coli-500ug |
|||
| QP8133-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human Acidic mammalian chitinase Protein, GST, E.coli-50ug |
|||
| QP8133-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Cryptosporidium Parvum CP Protein (aa 1-319) |
|||
| VAng-Cr4520-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5074.8 |
|
Description: Cryptosporidium Parvum (strain KSU-1) Capsid protein (CP), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum CP Protein (aa 1-319) |
|||
| VAng-Cr4520-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3591.6 |
|
Description: Cryptosporidium Parvum (strain KSU-1) Capsid protein (CP), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum CP Protein (aa 1-319) |
|||
| VAng-Cr4520-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2452.8 |
|
Description: Cryptosporidium Parvum (strain KSU-1) Capsid protein (CP), recombinant protein. |
|||
Recombinant human cDNA FLJ75527, highly similar to Homo sapiens zinc finger RNA binding protein (ZFR), mRNA |
|||
| P2185 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human cDNA FLJ75527, highly similar to Homo sapiens zinc finger RNA binding protein (ZFR), mRNA |
|||
Recombinant Cryptosporidium Parvum ACS Protein (aa 1-694) |
|||
| VAng-Cr4513-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Cryptosporidium Parvum Acetyl-coenzyme A synthetase (ACS), partial, recombinant protein. |
|||
Recombinant Cryptosporidium Parvum EF-2 Protein (aa 1-832) |
|||
| VAng-Cr4522-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Cryptosporidium Parvum Elongation factor 2, partial (EF-2), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd1_380 Protein (aa 1-305) |
|||
| VAng-Cr4515-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Cryptosporidium Parvum (strain Iowa II) Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (cgd1_380), partial, recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd2_4280 Protein (aa 1-410) |
|||
| VAng-Cr4516-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5768.4 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Structure-specific endonuclease subunit SLX1 homolog (cgd2_4280), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd2_4280 Protein (aa 1-410) |
|||
| VAng-Cr4516-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4068 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Structure-specific endonuclease subunit SLX1 homolog (cgd2_4280), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd2_4280 Protein (aa 1-410) |
|||
| VAng-Cr4516-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2782.8 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Structure-specific endonuclease subunit SLX1 homolog (cgd2_4280), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd6_20 Protein (aa 1-400) |
|||
| VAng-Cr4517-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5685.6 |
|
Description: Cryptosporidium Parvum Inosine-5'-monophosphate dehydrogenase (56k.02, cgd6_20), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd6_20 Protein (aa 1-400) |
|||
| VAng-Cr4517-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4018.8 |
|
Description: Cryptosporidium Parvum Inosine-5'-monophosphate dehydrogenase (56k.02, cgd6_20), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd6_20 Protein (aa 1-400) |
|||
| VAng-Cr4517-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2749.2 |
|
Description: Cryptosporidium Parvum Inosine-5'-monophosphate dehydrogenase (56k.02, cgd6_20), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd6_4130 Protein (aa 1-298) |
|||
| VAng-Cr4518-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4910.4 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Anamorsin homolog (cgd6_4130), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd6_4130 Protein (aa 1-298) |
|||
| VAng-Cr4518-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3474 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Anamorsin homolog (cgd6_4130), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd6_4130 Protein (aa 1-298) |
|||
| VAng-Cr4518-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2386.8 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Anamorsin homolog (cgd6_4130), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd7_4070 Protein (aa 1-366) |
|||
| VAng-Cr4519-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5421.6 |
|
Description: Cryptosporidium Parvum (strain Iowa II) ATPase ASNA1 homolog (cgd7_4070), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd7_4070 Protein (aa 1-366) |
|||
| VAng-Cr4519-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3837.6 |
|
Description: Cryptosporidium Parvum (strain Iowa II) ATPase ASNA1 homolog (cgd7_4070), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum cgd7_4070 Protein (aa 1-366) |
|||
| VAng-Cr4519-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2617.2 |
|
Description: Cryptosporidium Parvum (strain Iowa II) ATPase ASNA1 homolog (cgd7_4070), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum FEN1 Protein (aa 1-490) |
|||
| VAng-Cr4524-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 6378 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Flap endonuclease 1 (FEN1), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum FEN1 Protein (aa 1-490) |
|||
| VAng-Cr4524-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4497.6 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Flap endonuclease 1 (FEN1), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum FEN1 Protein (aa 1-490) |
|||
| VAng-Cr4524-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 3063.6 |
|
Description: Cryptosporidium Parvum (strain Iowa II) Flap endonuclease 1 (FEN1), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum PFOR Protein (aa 1-1934) |
|||
| VAng-Cr4525-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Cryptosporidium Parvum Pyruvate dehydrogenase [NADP (+) ] (PFOR), partial,, recombinant protein. |
|||
Recombinant Cryptosporidium Parvum RNR1 Protein (aa 1-803) |
|||
| VAng-Cr4527-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Cryptosporidium Parvum Ribonucleoside-diphosphate reductase large chain (RNR1), partial, recombinant protein. |
|||
Recombinant Cryptosporidium Parvum Actin Protein (aa 1-376) |
|||
| VAng-Cr4514-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5504.4 |
|
Description: Cryptosporidium Parvum Actin, recombinant protein. |
|||
Recombinant Cryptosporidium Parvum Actin Protein (aa 1-376) |
|||
| VAng-Cr4514-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3886.8 |
|
Description: Cryptosporidium Parvum Actin, recombinant protein. |
|||
Recombinant Cryptosporidium Parvum Actin Protein (aa 1-376) |
|||
| VAng-Cr4514-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2650.8 |
|
Description: Cryptosporidium Parvum Actin, recombinant protein. |
|||
Recombinant human Transforming acidic coiled-coil-containing protein 2 |
|||
| P2622 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Transforming acidic coiled-coil-containing protein 2 |
|||
Recombinant Human 60S acidic ribosomal protein P2 Protein, GST, E.coli-10ug |
|||
| QP8404-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human 60S acidic ribosomal protein P2 Protein, GST, E.coli-1mg |
|||
| QP8404-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human 60S acidic ribosomal protein P2 Protein, GST, E.coli-50ug |
|||
| QP8404-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human 60S acidic ribosomal protein P0 Protein, His, Yeast-1mg |
|||
| QP6623-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant (E.Coli, His-tag) Human Secreted Protein Acidic & Rich in Cysteine |
|||
| RP-992 | Alpha Diagnostics | 10 ug | EUR 270 |
Recombinant Cryptosporidium Parvum EIF4-A Protein (aa 1-405) |
|||
| VAng-Cr4523-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5718 |
|
Description: Cryptosporidium Parvum Eukaryotic initiation factor 4A (EIF4-A), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum EIF4-A Protein (aa 1-405) |
|||
| VAng-Cr4523-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4052.4 |
|
Description: Cryptosporidium Parvum Eukaryotic initiation factor 4A (EIF4-A), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum EIF4-A Protein (aa 1-405) |
|||
| VAng-Cr4523-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2766 |
|
Description: Cryptosporidium Parvum Eukaryotic initiation factor 4A (EIF4-A), recombinant protein. |
|||
Recombinant Human 60S acidic ribosomal protein P2 Protein, GST, E.coli-100ug |
|||
| QP8404-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human 60S acidic ribosomal protein P2 Protein, GST, E.coli-200ug |
|||
| QP8404-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human 60S acidic ribosomal protein P2 Protein, GST, E.coli-500ug |
|||
| QP8404-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human 60S acidic ribosomal protein P0 Protein, His, Yeast-100ug |
|||
| QP6623-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human 60S acidic ribosomal protein P0 Protein, His, Yeast-10ug |
|||
| QP6623-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human 60S acidic ribosomal protein P0 Protein, His, Yeast-200ug |
|||
| QP6623-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human 60S acidic ribosomal protein P0 Protein, His, Yeast-500ug |
|||
| QP6623-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant Human 60S acidic ribosomal protein P0 Protein, His, Yeast-50ug |
|||
| QP6623-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Acidic Nuclear Phosphoprotein 32 Family, Member A (ANP32A) recombinant protein |
|||
| RPJ636Hu01-200ug | Cloud-Clone | 200 ug | EUR 684.48 |
|
Description: This is Acidic Nuclear Phosphoprotein 32 Family, Member A (ANP32A) recombinant protein for Positive Control, Immunogen, SDS-PAGE, WB. It is in the form of freeze-dried powder in PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
|||
SPARC Secreted Protein acidic & Rich in Cysteine Human Recombinant Protein |
|||
| PROTP09486 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: Osteonectin Human Recombinant fused with 6X His tag produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 295 amino acids and having a molecular mass of 34 kDa.;The BM40 is purified by proprietary chromatographic techniques. |
|||
Recombinant Cryptosporidium Parvum EF-1-alpha Protein (aa 1-435) |
|||
| VAng-Cr4521-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5949.6 |
|
Description: Cryptosporidium Parvum Elongation factor 1-alpha (EF-1-alpha), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum EF-1-alpha Protein (aa 1-435) |
|||
| VAng-Cr4521-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4216.8 |
|
Description: Cryptosporidium Parvum Elongation factor 1-alpha (EF-1-alpha), recombinant protein. |
|||
Recombinant Cryptosporidium Parvum EF-1-alpha Protein (aa 1-435) |
|||
| VAng-Cr4521-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2865.6 |
|
Description: Cryptosporidium Parvum Elongation factor 1-alpha (EF-1-alpha), recombinant protein. |
|||
Recombinant Mouse Secreted Protein Acidic and Rich in Cysteine/SPARC (C-6His) |
|||
| CU38-10ug | Novoprotein | 10ug | EUR 169.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Secreted Protein Acidic and Rich in Cysteine/SPARC (C-6His) |
|||
| CU38-1mg | Novoprotein | 1mg | EUR 2008.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Precautionary resistance administration technique needs to be carried out. The phenomenon described within the examine may have broader organic significance.